Neuromeka Non-Registered Director Bak Jong-seok Acquires 16,760 Rights from Rights Offering, Slightly Increasing Specific Securities Holdings

According to the report, Neuromeka non-registered director Bak Jong-seok received 16,760 rights certificates from a shareholder-allotted rights offering on July 2, 2026, increasing his specific securities holdings from 65,067 to 81,827 shares.
The rights can be converted into new shares upon exercise, but the current common share holdings remain unchanged at 65,067 shares, with the common share ownership ratio slightly declining from 0.62% to 0.52% due to the inclusion of rights in the total specific securities count.
The specific use of proceeds from the rights offering is not disclosed in this report, but the small scale of the change suggests limited impact on overall shareholder value.
[AI Summary]The acquisition of rights by a Neuromeka non-registered director is a routine procedure following a rights offering and represents a minor change. The negligible movement in ownership percentage implies no direct impact on stock price and low investment risk.